Carlsbad-Based Alphatec Reports Third Quarter Loss

The medical technology firm posted a $5.5 million loss as quarterly revenue fell slightly short of analyst expectations.

Updated on Oct. 29, 2026 in Healthcare

Bold flat-color editorial illustration of a medical implant, evoking the precision and financial scrutiny of the medical technology sector. — Carlsbad-based Alphatec Holdings Inc. reported a $5.5 million net loss for the third quarter, trailing analyst revenue expectations by several million dollars. AI Illustration. Upload story photo >

Live Poll

Is now a good time to invest in companies with declining quarterly revenue?

Alphatec Holdings Inc., based in Carlsbad, reported a third-quarter net loss of $5.5 million. The results included a loss of 3 cents per share against quarterly revenue of $221.2 million.

Why it matters

The company's performance indicates ongoing financial challenges as it works to meet annual revenue targets. Market analysts had projected higher revenue, highlighting a gap between the firm's recent results and industry expectations.

Alphatec reported quarterly revenue of $221.2 million compared to the $224.3 million expected by analysts. The company maintained its guidance for full-year revenue at $862 million despite the third-quarter loss of 3 cents per share.

The players

Alphatec Holdings Inc.

This Carlsbad-based medical technology company specializes in surgical solutions for spinal disorders.

The details

While the firm reported a net loss, it noted adjusted earnings of 9 cents per share for the period. Alphatec remains focused on its full-year outlook as it navigates a year marked by significant stock price volatility.

Thursday, October 29, 2026: Financial results were officially released.
Q3 2026: The company recorded a $5.5 million net loss.
Beginning of the year: Company shares began a 46% decline.
Last 12 months: Shares have fallen 31%.

Market Landscape

Alphatec's financial results reflect broader competitive pressures currently impacting medical device manufacturers during the 2026 quarterly earnings cycle. This performance highlights the challenges firms face in balancing aggressive growth targets against market expectations.

Investors may see continued volatility in share prices following the company's latest financial report. Customers and partners should monitor if these fiscal results trigger any shifts in the firm's product development or service availability.

The takeaway

Alphatec faces a critical period to stabilize its market position after a year of significant stock declines. Shareholders and industry observers will look to future quarterly performance to see if the company can hit its $862 million annual revenue goal.